生姜用于活动性溃疡性结肠炎患者:一项随机对照试验的研究方案
本研究为一项12周、双盲、平行组随机对照试验,计划纳入44例活动性溃疡性结肠炎患者,随机分配至生姜胶囊组或安慰剂组,两组均接受基础常规治疗。主要结局为炎症标志物(TNF-α和hs-CRP)及总抗氧化能力。该试验旨在评估生姜补充对活动性UC患者的效应。
要点
- 生姜含抗氧化、抗炎及抗溃疡活性成分,可能对活动性UC患者有益。
- 试验采用12周双盲随机对照设计,样本量44例,两组均接受基础常规治疗。
- 主要结局为TNF-α、hs-CRP及总抗氧化能力。
核心结论
- 该试验旨在评估生姜补充对活动性溃疡性结肠炎患者的效应,结果尚待报告。
研究设计与样本
- 12周、双盲、平行组、随机对照试验,计划纳入44例活动性UC患者,随机分配至生姜胶囊组或安慰剂组,两组均接受基础常规治疗。
关键数值与推荐
- 主要结局为炎症标志物TNF-α和hs-CRP及总抗氧化能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As a lifetime disorder, ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that affects quality of life and also demands long-term interventions. In spite of considerable side effects and sometimes restricted uses, efficient medications are available for UC treatment. Some in vitro and in vivo examinations have correspondingly introduced ginger and its active components with antioxidant, anti-inflammatory, and anti-ulcerative properties. Therefore, this trial aims to evaluate the effect of ginger supplementation on patients with active UC. METHODS: This study will be a 12-week, double-blind, parallel-group, randomized, controlled trial (RCT) in which 44 patients will be allocated to ginger and placebo groups receiving basic routine treatments plus ginger or placebo capsules, respectively. The primary outcomes are inflammatory markers (TNF-α and hs-CRP) and total antioxidant capacity. DISCUSSION: The findings of this trial will provide evidence on the effect of ginger on patients with active UC. TRIAL REGISTRATION: Iranian Registry of Clinical Trials, IRCT20190129042552N1. Registered on 21 June 2019.
引用
- Shayesteh F, Haidari F, Shayesteh AA, et al. Ginger in patients with active ulcerative colitis: a study protocol for a randomized controlled trial. Trials. 2020. PMID: 32183895. doi:10.1186/s13063-020-4193-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。